HCPLive

AUGUST 21, 2024

This episode focuses on sotagliflozin in type 1 diabetes and other highlights from the ADCES 2024 annual meeting.

Diabetes 69

Diabetes 69

HCPLive

DECEMBER 18, 2023

This episode features a discussion on a pair of AID system integrations with the Dexcom G7 CGM system as well as important updates in the diabetes technology portion from the ADA's Standards of Care—2024.

Technology 69

Technology Diabetes 69

DAIC

JULY 10, 2024

Findings from an observational analysis of ARISE-HF trial participants, newly-published in the Journal of the American College of Cardiology, JACC, shed light on the racial and ethnic disparities in diabetic cardiomyopathy (DbCM), which researchers note may have the potential to inform clinical practice, interventions, and policies.

Cardiomyopathy 113

Cardiomyopathy Diabetes Health Disparities Exercise 113

HCPLive

DECEMBER 12, 2024

To celebrate surpassing 100 episodes, Diabetes Dialogue sits down with Irl Hirsch, MD, to discuss the 25-year anniversary of continuous glucose monitoring in 2024.

Diabetes 98

Diabetes 98

HCPLive

AUGUST 16, 2024

The first of 2 episodes on ADCES 2024, this episode focuses on sessions and presentations hosts Isaacs and Bellini participated in during the meeting.

Diabetes 69

Diabetes 69

HCPLive

JANUARY 10, 2024

In this episode, hosts discuss recent news and updates in diabetes technology from Abbott, Dexcom, and Medtronic in the first half of January 2024.

Technology 59

Technology Diabetes 59

HCPLive

FEBRUARY 27, 2024

Hosts break down their favorite sessions at the upcoming 17th International Conference on Advanced Technologies and Treatments for Diabetes.

Diabetes 64

Diabetes Technology 64

HCPLive

JUNE 17, 2024

This episode covers the clearance of 2 new OTC CGMs from Abbott, JDRF becoming Breakthrough T1D, and the FDA clearance of the CamAPS FX for people with T1D

Diabetes 78

Diabetes 78

HCPLive

NOVEMBER 21, 2024

In this episode, hosts break down a pair of studies from AHA 2024, BPROAD and SUMMIT, as well as a study in JAMA projecting semaglutide eligibility in US adults.

Diabetes 64

Diabetes 64

Medical Xpress - ECG

APRIL 8, 2024

An electronic sock that detects an unhealthy walking style linked with diabetes and poor circulation shows promise for preventing foot ulcers and amputation. The novel research is set to benefit the many patients with diabetes who have clogged arteries in the legs and is presented for the first time at EHRA 2024.

Diabetes 89

Diabetes Circulation Research 89

Dr. Paddy Barrett

FEBRUARY 21, 2025

Recent research suggested that the weight loss market was estimated to be worth $224 billion annually in 2021 and is estimated to exceed $400 billion by 2024 1. Type 2 Diabetes When it comes to the increasing the risk of major chronic diseases such as cardiovascular disease, many cancers and dementia, type 2 diabetes plays a huge role.

Obesity 77

Obesity Diabetes Cardiovascular Disease Chronic Disease 77

HCPLive

DECEMBER 29, 2023

Hosts discuss what they consider the most significant or relevant updates in the ADA's Standards of Care—2024, with a focus on new recommendations for glycemic management, bone health, immunizations, and weight management.

Diabetes 78

Diabetes 78

HCPLive

NOVEMBER 11, 2024

In this episode, hosts spotlight updates on Abbott’s Libre 3, Tidepool integration, and Omnipod 5 iOS app, expanding flexibility in diabetes management.

Diabetes 52

Diabetes 52

HCPLive

APRIL 19, 2024

In this episode, hosts break down the latest type 2 diabetes recommendations from the American College of Physicians and offer their perspective on second-line therapies in T2D.

Diabetes 52

Diabetes 52

DAIC

MARCH 14, 2025

Simultaneous pancreas-kidney (SPK) transplants are known to improve the quality of life and long-term survival of patients with insulin dependent diabetes and advanced renal disease. I have witnessed firsthand the significant benefits for patients with diabetes and kidney failure of receiving a pancreas and kidney transplant.

Heart Transplant 87

Heart Transplant Transplant Pediatrics Quality of Life 87

HCPLive

JANUARY 5, 2025

Our Endocrinology Month in Review for December 2024 highlights recent headlines in diabetes and endocrinology and 4 new episodes of Diabetes Dialogue.

Diabetes 59

Diabetes 59

HCPLive

DECEMBER 1, 2024

Our Endocrinology Month in Review for November 2024 highlights recent headlines in diabetes and endocrinology as well as 5 new episodes of Diabetes Dialogue.

Diabetes 59

Diabetes 59

HCPLive

DECEMBER 5, 2024

In this episode, hosts discuss the collaboration between Dexcom and Oura Ring, expanded compatibility of Omnipod 5 with Freestyle Libre 2, and Simplera CGM integration with the InPen.

Diabetes 59

Diabetes 59

HCPLive

MARCH 28, 2024

In this episode, all things AID from the 17th annual ATTD, including updates from Insulet Corporation and Omnipod, study data from the Control IQ algorithm, the SMASH study, and a peak into the future with the Neural Network AID algorithm.

Diabetes 72

Diabetes 72

HCPLive

SEPTEMBER 18, 2024

The FDA has approved the Eversense 365, the world’s first 1-year continuous glucose monitor, with US availability expected in late 2024.

Diabetes 105

Diabetes 105

Cardiometabolic Health Congress

JUNE 27, 2024

Neha Agarwal, PhD, Clinical Director at Cardiometabolic Health Congress , Informa Connect, recently presented significant findings at the 84th American Diabetes Association (ADA) Scientific Sessions. The Diabetes Track will feature: “Precision Medicine in Diabetes” by Jose C.

CME 59

CME Diabetes Obesity Education 59

Dr. Paddy Barrett

NOVEMBER 15, 2024

No Diabetes or Pre-Diabetes. 2024 Nov;30(11):1089-1096. npj Metab Health Dis 2 , 31 (2024). The Life Essential 8 are a set of factors that significantly influence your risk of heart disease and early death, including: Regular Physical Activity. Not smoking. Adequate Sleep. Normal Cholesterol Levels. Normal Blood Pressure.

Heart Disease 98

Heart Disease Obesity Blood Pressure Cholesterol 98

CardiacWire

JUNE 30, 2024

The first half of 2024 is now a wrap, and it was another big one in cardiology. GLP-1s are for CVD too – So far this year GLP-1s have gone from a weight loss and diabetes drug that “might” have cardiovascular benefits to becoming an FDA-approved and Medicare-covered option for CV event reduction.

Tricuspid 59

Tricuspid Reimbursement Medicare Electrophysiology 59

DAIC

MARCH 26, 2025

2 Most are balancing multiple comorbidities, such as obesity, diabetes, hypertension and chronic kidney disease (CKD). In fact, a 2024 report on heart failure trends and outcomes published in the Journal of Cardiac Failure showed that in patients with heart failure with preserved ejection fraction, 5-year mortality was 75.7%.

Heart Failure 52

Heart Failure Preserved Ejection Fraction Kidney Disease ACE Inhibitor 52

HCPLive

DECEMBER 8, 2024

A propensity score-matched study from ASH 2024 suggests GLP-1 RA use reduced VTE risk in type 2 diabetes.

Diabetes 64

Diabetes Strokes Stroke 64

HCPLive

AUGUST 4, 2024

The July 2024 endocrinology month in review recaps a pair of regulatory updates, multiple studies on incretin therapies, and the most recent episodes of our flagship diabetes podcast, Diabetes Dialogue.

Diabetes 52

Diabetes 52

HCPLive

OCTOBER 18, 2024

At AAO 2024, Cunningham describes the clinical response and safety of faricimab (Vabysmo) in underrepresented populations with diabetic macular edema.

Diabetes 111

Diabetes 111

Cardiovascular Diabetology

AUGUST 27, 2024

Objective We aimed to summarize the association between gestational diabetes mellitus (GDM) and its intergenerational cardiovascular diseases (CVDs) impacts in both mothers and offspring post-delivery in existing literature. All studies were evaluated using the Newcastle-Ottawa Scale.

Cardiovascular Disease 85

Cardiovascular Disease Diabetes Coronary Artery Disease Cerebrovascular Disease 85

HCPLive

OCTOBER 6, 2024

Our September 2024 monthly recap in endocrinology spotlights regulatory updates, new guidelines, and the latest episodes of Diabetes Dialogue.

Diabetes 52

Diabetes 52

HCPLive

OCTOBER 4, 2024

An EADV 2024 study suggests dupilumab use during pregnancy is generally safe and may lower risks of preterm labor, gestational hypertension, and diabetes.

Diabetes 110

Diabetes Outcomes Hypertension 110

HCPLive

SEPTEMBER 10, 2024

The endocrinology month in review for August 2024 spotlights 6 pieces of major pipeline news or regulatory announcements as well as multiple episodes of Diabetes Dialogue.

Diabetes 52

Diabetes 52

HCPLive

JUNE 5, 2024

Sadda, MD, and promising data from studies on geographic atrophy, diabetic macular ischemia, diabetic retinopathy, and AMD. This month-in-review features an exclusive interview with Srinivas R.

Ischemia 59

Ischemia Diabetes 59

Cardiometabolic Health Congress

SEPTEMBER 19, 2024

Developed by Senseonics and Ascensia Diabetes Care, the device represents a significant advancement in long-term glucose monitoring technology. The approval addresses several challenges faced by diabetes patients, including the inconvenience of frequent sensor changes, accidental dislodgement, and data interruptions.

Diabetes 59

Diabetes Technology Innovation 59

HCPLive

JULY 3, 2024

This episode focuses on 5 updates from the 84th American Diabetes Association (ADA) Scientific Sessions. Counting down the most impactful news at major medical meetings, it’s the HCPLive Five!

Diabetes 59

Diabetes 59

HCPLive

MARCH 26, 2024

In this peisode, hosts disucss top news and updates in automated insulin delivery from ATTD 2024, with a focus on new data from the T1D Exchange and a read-out from the CRISTAL study.

Diabetes 52

Diabetes 52

Cardiometabolic Health Congress

JUNE 14, 2024

Recent over-the-counter (OTC) approvals for CGM systems are transforming diabetes management and lifestyle management for those without diabetes, making this an exciting time for healthcare professionals and their patients. These enhancements offer benefits beyond diabetes management, including support for women across the lifespan.

Technology 105

Technology Diabetes Outcomes Innovation 105

HCPLive

MARCH 30, 2024

In this episode, hosts discuss GLP-1 RA use and CGM technology, updates in once-weekly insulins, the concept of continuous ketone monitoring, and practical application of artificial intelligence into care.

Diabetes 59

Diabetes Technology 59